BioRestorative Therapies, Inc. (BRTX)
Oxford Ledge is still expanding full research coverage of BRTX. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
BioRestorative Therapies develops stem cell-based therapies for spine disease, metabolic disorders, and cosmetic products.
SEC filings
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-06-12
- 8-K Entry into material agreement; Departure/election of directors or officers; Financial statements and exhibits 2026-06-12
- 8-K Departure/election of directors or officers; Shareholder vote results; Financial statements and exhibits 2026-05-29
- 10-Q Quarterly financial report (unaudited) 2026-05-14
- 8-K Departure/election of directors or officers 2026-05-01
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for BRTX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open BRTX in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.